RE:RE:Wow look at the EATS chart!This isn't the first time EATS has dropped by half. Previously it went from 3.05 to 1.67, but it did so a lot more quickly and dramatically. After that it started to consolidate into a gradual rise that continued to $4.50 :)
I agree the momentum in EATS is astrounding, which makes me wonder if the fall could continue...? But I am reminded that the current fall reflects investors chopping risk from their portfolios more than it does how EATS is performing. EATS as a company looks awesome to me - they are active, expanding, highly involved in their companies, and posting astrounding returns on their investments (a little weaker now, but still 15x ROI). If Nabati and Eat Just IPO this year, we will see and feel more of that.
The question is only what's the bottom and how high will the next rise be? Your saying $1 but offer no analysis - I laugh at that. At a buck EATS would be undervalued with respect to its book value (see my analysis in previous post), and that seems very unlikely in this trasformative biotech growth space. I think this is the bottom.